Prevalence and correlates of genital warts in Kenyan female sex workers

Sex Transm Dis. 2012 Nov;39(11):902-5. doi: 10.1097/OLQ.0b013e318275ec7f.

Abstract

Background: Our goal in the present study was to investigate the prevalence and correlates of genital warts in a population of female sex workers in Mombasa, Kenya. Because of the high prevalence of human immunodeficiency virus type 1 (HIV-1) in this population, we were particularly interested in the association between HIV-1 infection and genital warts.

Methods: We conducted a cross-sectional study of the prevalence and correlates of genital warts among high-risk women in Mombasa, Kenya. Between 2001 and 2007, 1182 women were enrolled, of whom 613 (51.4%) were HIV-1 seropositive. Chi square tests and logistic regression were used to examine the associations between genital warts and potential correlates.

Results: Genital warts were identified on clinical examination in 27 (2.3%) women. Women who were HIV-1 seropositive were nearly 8 times as likely to have genital warts compared with HIV-1-seronegative women (odds ratio, 7.69; 95% confidence interval, 2.30-25.6).

Conclusion: Understanding the prevalence and correlates of genital warts will help to determine whether coverage for the wart-inducing subtypes 6 and 11 in a human papillomavirus vaccine is an important consideration in resource-limited countries.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • AIDS-Related Opportunistic Infections / epidemiology*
  • AIDS-Related Opportunistic Infections / prevention & control
  • Adult
  • Alphapapillomavirus / drug effects
  • Alphapapillomavirus / immunology
  • Alphapapillomavirus / isolation & purification*
  • Chi-Square Distribution
  • Condylomata Acuminata / epidemiology*
  • Condylomata Acuminata / prevention & control
  • Cross-Sectional Studies
  • Female
  • Genital Diseases, Female / epidemiology*
  • Genital Diseases, Female / prevention & control
  • Genitalia, Female / virology*
  • Humans
  • Kenya / epidemiology
  • Logistic Models
  • Papillomavirus Vaccines / pharmacology
  • Physical Examination
  • Prevalence
  • Risk Factors
  • Sex Workers

Substances

  • Papillomavirus Vaccines